PowderJect forecasts jump in flu vaccine sales

Pharmaceutical firm PowderJect today forecasted sales of its flu vaccine in the coming year would jump more than 40% over last year’s figure.

The global flu vaccine market - currently worth £340m is expected to be worth £610m by 2005, the Oxford-based firm said.